Transformational Therapies for Neurological Diseases

Corlieve Therapeutics develops first and best in class medicines for specific neuronal targets that have the potential to transform patients’ lives. Corlieve brings together breakthrough neurological research with transformational drug delivery technologies to produce clinically meaningful therapies.

Corlieve’s initial programme is founded on the discovery of novel targets for the treatment of drug resistant temporal lobe epilepsy and leverages innovative gene therapy approaches.